MedPath

To Study the effect of Punarnavadi Tablet in the management of Physiological Oedema in Pregnancy.

Phase 2
Conditions
Health Condition 1: O120- Gestational edema
Registration Number
CTRI/2023/02/049885
Lead Sponsor
Dr. Pratiksha Madanraj Lade
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pregnant of 3rd trimester.

Primi Gravida and Multi Gravida.

Patient having bilateral Oedema.

Exclusion Criteria

Anaemia

Gestational Diabetes Mellitus

Oligohydraminos

Polyhydraminos

Pregnancy Induced Hypertension

Renal Disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Reduce Swelling (Padashotha), Heaviness.Timepoint: 14 days study with follow up on 7th and 14th day.
Secondary Outcome Measures
NameTimeMethod
To observe adverse effect, if any.Timepoint: 14 days study with follow up on 7th and 14th day.
© Copyright 2025. All Rights Reserved by MedPath